UK falls from fourth to 10th place in phase III trials amid ‘ossified’ bureaucracy and stretched health service
The state of clinical trials in the NHS is “much worse than it has been in years” with patients losing access to cutting-edge cancer and dementia treatments, one of the UK’s most senior clinicians has warned.
Sir John Bell, regius professor of medicine at the University of Oxford and a government life sciences adviser, said the UK’s approach needed “a full overhaul, top-to-bottom” to prevent a collapse in the number of clinical trials being conducted in the NHS.
